The serum levels of IL‐8 and S100A4 steadily increased following stage‐by‐stage PCa metastatic progression, suggesting that IL‐8 and S100A4 may serve as metastatic PCa biomarkers beyond PSA (Figure 7B,C). Here, CXCL8 is linked to posterior cortical atrophy.